GlassScriptPhysician profile
Hsien Cheng Young
NPI 1528162757
$13,068.62
in general payments reported to CMS, 2019-2025
60 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what 75% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,541 · 2020: $650 · 2021: $656 · 2022: $1,761 · 2023: $2,048 · 2024: $3,168 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,428 · Education: $31.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,427.90 |
| Education | $31.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,237.91 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Novartis Pharmaceuticals Corporation | $1,027.56 | 2019-2025 | |
| Inspire Medical Systems, INC. | $972.39 | 2023-2025 | Inspire |
| Ucb, INC. | $622.93 | 2019-2024 | Rystiggo, Briviact |
| Biogen, INC. | $501.41 | 2019-2024 | Vumerity |
| Emd Serono, INC. | $500.05 | 2019-2024 | Mavenclad |
| Genzyme Corporation | $466.45 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $460.00 | 2019-2024 | Austedo Xr, Austedo, Ajovy |
| Lilly USA, LLC | $397.78 | 2019-2025 | Emgality, Zepbound, Reyvow |
| Tg Therapeutics, INC. | $395.41 | 2023-2024 | |
| Pfizer INC. | $343.82 | 2019-2025 | |
| Amgen INC. | $307.28 | 2019-2024 | Uplizna |
| Harmony Biosciences LLC | $294.81 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $287.15 | 2019-2024 | Ultomiris |
| Eisai INC. | $285.52 | 2019-2025 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hsien Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.